Spermatogonial survival in long-term human prepubertal xenografts

Ellen Goossens1, Mieke Geens, Gert De Block

  • 1Centre for Reproductive Medicine and Research Laboratories for Reproductive Medicine, University Hospital and Medical School, Dutch-speaking Brussels, Free UniversityVrije Universiteit Brussel, Brussels, Belgium. ellen.goossens@uzbrussel.be

Insights

Future fertility restoration for prepubertal boys undergoing cancer treatment may be possible. Xenografting prepubertal testicular tissue in mice showed survival of key cells, suggesting a viable future fertility preservation strategy.

Area of Science:

  • Reproductive biology
  • Oncology
  • Transplantation immunology

Background:

  • Childhood cancer survival rates are increasing, but treatment-induced sterility is a significant concern.
  • Current fertility preservation options are limited for prepubertal boys.
  • Testicular tissue banking and subsequent grafting show promise as a future fertility strategy.

Purpose of the Study:

  • To investigate the feasibility of xenografting prepubertal human testicular tissue.
  • To assess the survival and function of testicular cells after grafting in an animal model.

Main Methods:

  • Prepubertal human testicular tissue from two patients undergoing chemotherapy was xenografted onto immunodeficient mice.
  • Immunohistochemistry using MAGE-A4 and vimentin antibodies was employed to identify specific cell types post-grafting.

Main Results:

  • Spermatogonia (MAGE-A4 positive) and Sertoli cells (vimentin positive) were successfully identified four months after xenografting.
  • Evidence of cell survival indicates successful engraftment and potential for continued development.

Conclusions:

  • Xenografting of prepubertal testicular tissue is a viable method for preserving fertility cells.
  • This approach holds potential for restoring fertility in prepubertal male cancer survivors.